Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.

Stella Tsai CS, Chen HC, Tung JN, Tsou SS, Tsao TY, Liao CF, Chen YC, Yeh CY, Yeh KT, Jiang MC.

Am J Pathol. 2010 Apr;176(4):1619-28. doi: 10.2353/ajpath.2010.090467.

2.

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.

Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S, Murray GI.

J Pathol. 2012 Dec;228(4):471-81. doi: 10.1002/path.4031.

PMID:
22450763
3.

CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.

Jiang MC, Yeh CM, Tai CJ, Chen HC, Lin SH, Su TC, Shen SC, Lee WR, Liao CF, Li LT, Lee CH, Chen YC, Yeh KT, Chang CC.

Am J Surg. 2013 Sep;206(3):418-27. doi: 10.1016/j.amjsurg.2012.11.021.

PMID:
23806821
4.

Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.

Tai CJ, Su TC, Jiang MC, Chen HC, Shen SC, Lee WR, Liao CF, Chen YC, Lin SH, Li LT, Shen KH, Yeh CM, Yeh KT, Lee CH, Shih HY, Chang CC.

J Transl Med. 2013 Jan 31;11:29. doi: 10.1186/1479-5876-11-29.

5.

Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer.

Tung MC, Tsai CS, Tung JN, Tsao TY, Chen HC, Yeh KT, Liao CF, Jiang MC.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1570-7. doi: 10.1158/1055-9965.EPI-08-0948.

6.

Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.

Lee WR, Shen SC, Shih YH, Chou CL, Tseng JT, Chin SY, Liu KH, Chen YC, Jiang MC.

J Transl Med. 2015 Jun 13;13:191. doi: 10.1186/s12967-015-0553-6.

7.

Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.

Tai CJ, Hsu CH, Shen SC, Lee WR, Jiang MC.

J Exp Clin Cancer Res. 2010 Aug 11;29:110. doi: 10.1186/1756-9966-29-110. Review.

8.

The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.

Yuksel UM, Dilek G, Dogan L, Gulcelik MA, Berberoglu U.

Tumori. 2015 Mar-Apr;101(2):194-8. doi: 10.5301/tj.5000239.

PMID:
25791533
9.

Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?

Yuksel UM, Turker I, Dilek G, Dogan L, Gulcelik MA, Oksuzoglu B.

Oncol Res Treat. 2015;38(9):431-4. doi: 10.1159/000438501.

PMID:
26278417
10.

CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.

Liao CF, Lin SH, Chen HC, Tai CJ, Chang CC, Li LT, Yeh CM, Yeh KT, Chen YC, Hsu TH, Shen SC, Lee WR, Chiou JF, Luo SF, Jiang MC.

Mol Med. 2012 Dec 6;18:1269-80. doi: 10.2119/molmed.2012.00205.

11.

CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.

Liao CF, Luo SF, Li LT, Lin CY, Chen YC, Jiang MC.

J Exp Clin Cancer Res. 2008 Jul 3;27:15. doi: 10.1186/1756-9966-27-15.

12.

Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium.

Uen WC, Tai CJ, Shen SC, Lee WR, Tsao TY, Deng WP, Chiou HY, Hsu CH, Hsieh CI, Liao CF, Jiang MC.

J Mol Histol. 2010 Oct;41(4-5):259-66. doi: 10.1007/s10735-010-9286-2.

PMID:
20734115
13.

Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.

Zhu JH, Hong DF, Song YM, Sun LF, Wang ZF, Wang JW.

Asian Pac J Cancer Prev. 2013;14(2):1017-21.

14.

Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon.

Tsao TY, Tsai CS, Tung JN, Chen SL, Yue CH, Liao CF, Wang CC, Jiang MC.

Mol Cell Biochem. 2009 Jul;327(1-2):163-70. doi: 10.1007/s11010-009-0054-0.

PMID:
19224336
15.

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Ann Surg. 2014 Apr;259(4):735-43. doi: 10.1097/SLA.0b013e3182a6909d.

16.
17.

Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer.

Zhong W, Yu Z, Zhan J, Yu T, Lin Y, Xia ZS, Yuan YH, Chen QK.

Pathol Oncol Res. 2015 Jan;21(1):83-95. doi: 10.1007/s12253-014-9791-9.

PMID:
24875250
18.
19.

Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer.

Huh JW, Lee WY, Park YA, Cho YB, Yun SH, Kim HC, Chun HK.

J Cancer Res Clin Oncol. 2014 Mar;140(3):435-41. doi: 10.1007/s00432-013-1580-4.

PMID:
24414039
20.

The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.

Lorenzato A, Martino C, Dani N, Oligschläger Y, Ferrero AM, Biglia N, Calogero R, Olivero M, Di Renzo MF.

FASEB J. 2012 Jun;26(6):2446-56. doi: 10.1096/fj.11-195982.

PMID:
22389439

Supplemental Content

Support Center